Catawba Research Collaborates With Bingli Inc. to Make Patient Pre-Screening Easier for Participants and Sites

February 6, 2024

CHARLOTTE, N.C.; Feb. 6, 2024 Catawba Research, a leading global clinical research organization (CRO) that has established itself as a trusted partner in the development of new drugs, devices, and diagnostics with a strong focus on delivering high-quality tech-enabled research solutions, announced a new collaboration with Bingli Inc., which provides AI- guided diagnosis, disease management, and navigation for patients and healthcare providers. All Catawba’s clinical studies may now offer candidates pre-screening via Bingli’s smart clinical trial technology that includes rigorous disease scoring system outcomes and delivers a highly enriched candidate pool for real-time recruitment management. 

“At Catawba Research, we are creating value in clinical research by identifying and incorporating the best technology solutions to speed recruitment, the biggest challenge currently facing our industry,” said Catawba Chief Executive Officer Andrew Silverman, Ph.D. “Partnering with Bingli gives us a powerful tool to streamline participation, reduce site burden, and save time for potential participants as they explore their clinical trial options.” 

Applying Bingli’s technology platform will allow Catawba to reduce trial costs, eliminating a higher proportion of ineligible subjects compared to traditional pre-screening methods. The AI solution sends approximately 3% of candidates to sites, reducing failed screens by up to 75%. With a Bingli referral, a candidate is three to four times as likely to be eligible. Bingli delivers extraordinary value to sponsors and CROs by reducing site burden and delivering candidates highly likely to convert to enrolled subjects. 

“Bingli’s candidate pre-screening application was added to our overall healthcare AI, self-learning platform to quickly provide real-time, deep understanding of pre-screening eligibility results,” said Bingli U.S. Chief Medical Officer Cees Wortel, M.D., Ph.D. “Our solution uses a unique, smart white box AI technology that incorporates sophisticated disease ratings aided by examples, such as diagnostic example images and eligibility assessments. At Bingli we care about clinical trial participation as a cornerstone of healthcare and health provision and our solution delivers shorter timelines and lower site workload all while increasing the success potential of each participant asynchronously.” 

About Catawba Research 
Catawba Research is a leading contract research organization specializing in clinical research and development services for the pharmaceutical, biotechnology, and medical device industries. With a strong commitment to quality, innovation, and client satisfaction, Catawba Research delivers comprehensive solutions to advance healthcare products from concept to market. For more information, please visit

About Bingli Inc. 
Bingli delivers person centered, digital health solutions through dynamic, intelligent medical history and patient assessments. Bingli’s AI-powered medical practice and clinical research optimization platform is built around self-learning diagnostic reasoning and virtual patient engagement solutions for both patients and healthcare professionals. For more information, please visit

Copyright © 2021 · Catawba Research, LLC